- Filed
- Jul 24, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 14.31M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 14.4M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 14.33M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $953K |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Dividends Paid | Q1 2025 · Mar 31, 2025 | $2.88M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $2.57M |
| Capex | Q1 2025 · Mar 31, 2025 | $749K |
| Capex | Q1 2025 · Mar 31, 2024 | $2.22M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | $2.35M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $8.25M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $214.35M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $198.79M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2025 | $370.86M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $363.81M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $350.01M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $348.87M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.81B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.7B |
| Total Assets restated | Q1 2025 · Mar 31, 2025 | $3.18B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.06B |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | $0.53 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.33 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | $0.53 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.33 |
| Net Income | Q1 2025 · Mar 31, 2025 | $7.74M |
| Net Income | Q1 2025 · Mar 31, 2024 | $4.69M |
| Revenue | Q1 2025 · Mar 31, 2025 | $666K |
| Revenue | Q1 2025 · Mar 31, 2024 | $671K |